Patent Assignment
Reel/Frame 052931/0142
Security Interest
Recorded: 2020-06-12
Pages: 118
Assignor
ADC THERAPEUTICS SA
Executed: 2020-05-19
Assignee
DEERFIELD PARTNERS, L.P.
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Property
(1)
Humanized Anti-Axl Antibodies and Their Conjugates
Application:
15/566,639 →
Publication:
US 2018/0127505
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 9, 2019
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS; A.T. DEVELOPMENT SWITZERLAND SÀRL
To: ADC THERAPEUTICS S.A.
Reel/Frame 049132/0181 →
Assignment of Assignor's Interest
May 9, 2019
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 049132/0197 →
Assignment of Assignor's Interest
May 15, 2019
From: WILLIAMS, DAVID GARETH; DATAMABS LIMITED; A.T. DEVELOPMENT SWITZERLAND SÀRL
To: ADC THERAPEUTICS S.A.
Reel/Frame 049180/0224 →
Security Interest
May 19, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P., AS GRANTEE
Reel/Frame 052696/0247 →
Termination and Release of Patent Security Agreement
Aug 16, 2022
From: DEERFIELD PARTNERS, L.P.
To: ADC THERAPEUTICS SA
Reel/Frame 061200/0750 →